A citation-based method for searching scientific literature

Robert J Motzer, Bernard Escudier, David F McDermott, Saby George, Hans J Hammers, Sandhya Srinivas, Scott S Tykodi, Jeffrey A Sosman, Giuseppe Procopio, Elizabeth R Plimack, Daniel Castellano, Toni K Choueiri, Howard Gurney, Frede Donskov, Petri Bono, John Wagstaff, Thomas C Gauler, Takeshi Ueda, Yoshihiko Tomita, Fabio A Schutz, Christian Kollmannsberger, James Larkin, Alain Ravaud, Jason S Simon, Li-An Xu, Ian M Waxman, Padmanee Sharma. N Engl J Med 2015
Times Cited: 3277



Stephen M Ansell, Alexander M Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C Scott, Martin Gutierrez, Stephen J Schuster, Michael M Millenson, Deepika Cattry, Gordon J Freeman, Scott J Rodig, Bjoern Chapuy, Azra H Ligon, Lili Zhu, Joseph F Grosso, Su Young Kim, John M Timmerman, Margaret A Shipp, Philippe Armand. N Engl J Med 2015
Times Cited: 2238




List of shared articles



Times cited

Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer.
T Enomoto, A Tamiya, K Matsumoto, Y Adachi, K Azuma, Y Inagaki, S Kouno, Y Taniguchi, N Saijo, K Okishio,[...]. Clin Transl Oncol 2021
0

Enhanced Antitumor Immunity via Endocrine Therapy Prevents Mammary Tumor Relapse and Increases Immune Checkpoint Blockade Sensitivity.
Gonzalo R Sequeira, Ana Sahores, Tomás Dalotto-Moreno, Ramiro M Perrotta, Gabriela Pataccini, Silvia I Vanzulli, María L Polo, Derek C Radisky, Carol A Sartorius, Virginia Novaro,[...]. Cancer Res 2021
3

Z-guggulsterone induces PD-L1 upregulation partly mediated by FXR, Akt and Erk1/2 signaling pathways in non-small cell lung cancer.
Han Tian, Yanni Gui, Yuanhui Wei, Bin Shang, Jian Sun, Shan Ma, Wenjie You, Shujuan Jiang. Int Immunopharmacol 2021
0

PILE: a candidate prognostic score in cancer patients treated with immunotherapy.
D C Guven, H C Yildirim, E Bilgin, O H Aktepe, H Taban, T K Sahin, I Y Cakir, S Akin, O Dizdar, S Aksoy,[...]. Clin Transl Oncol 2021
1

Combination of radiation therapy for brain metastasis and anti-PD-1/PD-L1 treatment in non-small cell lung cancer: two cases and review of the literature.
Olga Nigro, Alessandro Tuzi, Andrea Coppola, Tiziana Tartaro, Claudio Chini, Graziella Pinotti. Anticancer Drugs 2021
0

The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.
Ming Yi, Jing Zhang, Anping Li, Mengke Niu, Yongxiang Yan, Ying Jiao, Suxia Luo, Pengfei Zhou, Kongming Wu. J Hematol Oncol 2021
13

Neurological complications of immune checkpoint inhibitor cancer immunotherapy.
Cecilia Zivelonghi, Anastasia Zekeridou. J Neurol Sci 2021
0

Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects.
Adriana Petrazzuolo, Maria Perez-Lanzon, Isabelle Martins, Peng Liu, Oliver Kepp, Véronique Minard-Colin, Maria Chiara Maiuri, Guido Kroemer. Cell Death Dis 2021
0

The role of the bacterial microbiome in the treatment of cancer.
Zi-Kun Yu, Rui-Ling Xie, Rui You, You-Ping Liu, Xu-Yin Chen, Ming-Yuan Chen, Pei-Yu Huang. BMC Cancer 2021
1



Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition.
Jianda Yuan, Anuradha Khilnani, Joshua Brody, Robert H I Andtbacka, Siwen Hu-Lieskovan, Jason J Luke, Adi Diab, Aurelien Marabelle, Alexandra Snyder, Z Alexander Cao,[...]. Eur J Cancer 2021
0

0

Immune landscape and therapeutic strategies: new insights into PD-L1 in tumors.
Yuan Wei, Xiao Xiao, Xiang-Ming Lao, Limin Zheng, Dong-Ming Kuang. Cell Mol Life Sci 2021
1